MORSE DANIEL E. 4
4 · Stellar Biotechnologies, Inc. · Filed Mar 14, 2018
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Award
Share Option (Right to Buy)
2018-03-12+2,500→ 2,500 totalExercise: $0.84Exp: 2025-03-12→ Common Shares (2,500 underlying) - Sale
Common shares, without par value
2018-02-28$0.79/sh−7,000$5,530→ 14,866 total(indirect: By Spouse) - Sale
Common shares, without par value
2018-03-09$0.81/sh−7,000$5,635→ 7,866 total(indirect: By Spouse) - Sale
Common Shares, without par value
2018-02-22$0.78/sh−7,800$6,115→ 28,866 total(indirect: By Spouse) - Sale
Common shares, without par value
2018-02-26$0.79/sh−7,000$5,530→ 21,866 total(indirect: By Spouse) - Sale
Common shares, without par value
2018-03-12$0.80/sh−3,500$2,790→ 4,366 total(indirect: By Spouse)
Holdings
- 194,523
Common Shares, without par value
Footnotes (1)
- [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019.